Product Information
TEMAZEPAM 15 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.0791 per EA under NDC 00228207610. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 7, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228207610
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071620FDA Approved
8/7/1987
TE Code
AB
On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 15 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 32.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0791 per EA |
|---|---|
| All-time high | $0.0822 (May 11, 2022) |
| All-time low | $0.0537 (Oct 21, 2015) |
| 52-week high | $0.0793 |
| 52-week low | $0.0756 |
| Median price | $0.0716 |
| Average price | $0.0706 |
| Largest weekly change | -29.8% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMAZEPAM 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 15 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.0791 per EA (NDC 00228207610), effective Aug 19, 2026.
How has the price of TEMAZEPAM 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 15 MG CAPSULE has risen 32.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 15 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 15 MG CAPSULE has ranged from a low of $0.0537 (Oct 21, 2015) to a high of $0.0822 (May 11, 2022), with a median of $0.0716 per EA.
Are there cheaper alternatives to TEMAZEPAM 15 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 15 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 15 MG CAPSULE?
TEMAZEPAM 15 MG CAPSULE (NDC 00228207610) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.